Skip to main content
Equibles
COR logo

COR · Cencora, Inc. · Earnings Call Transcripts & Audio

Track COR — free

Use COR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research COR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$300.25 -7.35 (-2.39%) At close · Sep 30
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$57.74B
Shares
190.83M
Volume · Sep 30 1.81M Avg daily vol (3M) 1.38M

Cencora, Inc. Earnings Call Transcripts

Quarterly earnings calls for Cencora, Inc. (COR), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲3.8% $61.17B $294.74M '22 Q4 22-11-03 ▲5.4% $62.85B $479.75M '23 Q1 23-02-01 ▲9.9% $63.46B $435.40M '23 Q2 23-05-02 ▲11.5% $66.95B $479.58M '23 Q3 23-08-02 ▲12.7% $68.92B $350.56M '23 Q4 23-11-02 ▲15% $72.25B $601.50M '24 Q1 24-01-31 ▲7.8% $68.41B $420.77M '24 Q2 24-05-01 ▲10.9% $74.24B $483.46M '24 Q3 24-07-31 ▲14.7% $79.05B $3.38M '24 Q4 24-11-06 ▲12.8% $81.49B $488.60M '25 Q1 25-02-05 ▲10.3% $75.45B $717.87M '25 Q2 25-05-07 ▲8.7% $80.66B $687.40M '25 Q3 25-08-06 ▲5.9% $83.73B −$339.70M '25 Q4 25-11-05 ▲5.5% $85.93B $559.65M '26 Q1 26-02-04 ▲3.8% $78.36B $1.64B '26 Q2 26-05-06 LATEST ▲5.1% $84.75B $763.52M '26 Q3 26-08-05
Conference
Investor event
2026-09-15
Cencora, Inc. (COR) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-08
Cencora, Inc. (COR) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-08-05
Cencora, Inc. (COR) Q3 2026 Earnings Call Transcript
Confident tone Specialty pharmaceutical platform and growth Talent and leadership transitions International / European distribution strength
Revenue
$84.75B
▲ 5.1% YoY
Diluted EPS
$3.94
▲ 11.9% YoY
Gross margin
4.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-05-06
Cencora, Inc. (COR) Q2 2026 Earnings Call Transcript
Positive tone Specialty pharmaceuticals and MSO platform EPS growth and fiscal 2026 guidance Capital deployment and share repurchases
Revenue
$78.36B
▲ 3.8% YoY
Diluted EPS
$8.40
▲ 128.3% YoY
Gross margin
4.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-10
Cencora, Inc. (COR) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-02-04
Cencora, Inc. (COR) Q1 2026 Earnings Call Transcript
Confident tone MSO expansion and acquisitions Guidance raise Specialty pharmaceuticals leadership
Revenue
$85.93B
▲ 5.5% YoY
Diluted EPS
$2.87
▲ 14.8% YoY
Gross margin
3.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-11-05
Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript
Confident tone Strategic portfolio review / divestitures Capital deployment Specialty growth and positioning
Revenue
$83.73B*
▲ 5.9% YoY
Gross margin
3.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-08-06
Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript
Positive tone Specialty Pharmaceuticals and RCA GLP-1 Profitability Outlook Pharmaceutical Distribution and DSCSA
Revenue
$80.66B
▲ 8.7% YoY
Diluted EPS
$3.52
▲ 45.5% YoY
Gross margin
3.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-05-07
Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript
Confident tone Specialty Pharmaceuticals & Global Leadership MSOs / M&A (One Oncology, RCA) Guidance Raise & EPS Growth
Revenue
$75.45B
▲ 10.3% YoY
Diluted EPS
$3.68
▲ 76.1% YoY
Gross margin
4.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-02-05
Cencora, Inc. (COR) Q1 2025 Earnings Call Transcript
Confident tone Specialty growth and acquisitions COVID vaccine headwind World Courier / clinical trial softness
Revenue
$81.49B
▲ 12.8% YoY
Diluted EPS
$2.50
▼ 16.1% YoY
Gross margin
3.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-11-06
Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript
Positive tone RCA Acquisition and Specialty Expansion CEO Transition IRA and Regulatory Policy
Revenue
$79.05B*
▲ 14.7% YoY
Gross margin
3.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-07-31
Cencora, Inc. (COR) Q3 2024 Earnings Call Transcript
Confident tone Quarterly financial performance and raised outlook Good Neighbor Pharmacy and ThoughtSpot Pharmaceutical-centric strategy and integrated solutions
Revenue
$74.24B
▲ 10.9% YoY
Diluted EPS
$2.42
▲ 3% YoY
Gross margin
3.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-05-01
Cencora, Inc. (COR) Q2 2024 Earnings Call Transcript
Confident tone Financial results and EPS growth CEO succession Pharmaceutical manufacturers and commercialization services
Revenue
$68.41B
▲ 7.8% YoY
Diluted EPS
$2.09
▼ 1.9% YoY
Gross margin
3.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-01-31
Cencora, Inc. (COR) Q1 2024 Earnings Call Transcript
Confident tone Full-Year Guidance Raise GLP-1 Demand and Growth International Segment and Egypt Headwind
Revenue
$72.25B
▲ 15% YoY
Diluted EPS
$2.98
▲ 27.9% YoY
Gross margin
3.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-11-02
Cencora, Inc. (COR) Q4 2023 Earnings Call Transcript
Revenue
$68.92B*
▲ 12.7% YoY
Gross margin
3.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-08-02
Cencora, Inc. (COR) Q3 2023 Earnings Call Transcript
Revenue
$66.95B
▲ 11.5% YoY
Diluted EPS
$2.35
▲ 22.4% YoY
Gross margin
3.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-05-02
Cencora, Inc. (COR) Q2 2023 Earnings Call Transcript
Revenue
$63.46B
▲ 9.9% YoY
Diluted EPS
$2.13
▼ 17.8% YoY
Gross margin
3.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-02-01
Cencora, Inc. (COR) Q1 2023 Earnings Call Transcript
Revenue
$62.85B
▲ 5.4% YoY
Diluted EPS
$2.33
▲ 9.4% YoY
Gross margin
3.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-11-03
Cencora, Inc. (COR) Q4 2022 Earnings Call Transcript
Revenue
$61.17B*
▲ 3.8% YoY
Gross margin
3.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-08-03
Cencora, Inc. (COR) Q3 2022 Earnings Call Transcript
Revenue
$60.06B
▲ 12.5% YoY
Diluted EPS
$1.92
▲ 37.1% YoY
Gross margin
3.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-05-04
Cencora, Inc. (COR) Q2 2022 Earnings Call Transcript
Revenue
$57.72B
▲ 17.4% YoY
Diluted EPS
$2.59
▲ 23.3% YoY
Gross margin
3.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-02-02
Cencora, Inc. (COR) Q1 2022 Earnings Call Transcript
Revenue
$59.63B
▲ 13.5% YoY
Diluted EPS
$2.13
▲ 17.7% YoY
Gross margin
3.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-11-04
Cencora, Inc. (COR) Q4 2021 Earnings Call Transcript
Revenue
$58.91B*
▲ 19.6% YoY
Gross margin
3.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-08-04
Cencora, Inc. (COR) Q3 2021 Earnings Call Transcript
Revenue
$53.41B
▲ 17.7% YoY
Diluted EPS
$1.40
▼ 0.7% YoY
Gross margin
3.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-05-05
Cencora, Inc. (COR) Q2 2021 Earnings Call Transcript
Revenue
$49.15B
▲ 3.7% YoY
Diluted EPS
$2.10
▼ 54.7% YoY
Gross margin
3.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-02-04
Cencora, Inc. (COR) Q1 2021 Earnings Call Transcript
Revenue
$52.52B
▲ 9.7% YoY
Diluted EPS
$1.81
▲ 101.1% YoY
Gross margin
2.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-11-05
Cencora, Inc. (COR) Q4 2020 Earnings Call Transcript
Revenue
$49.24B
▲ 7.9% YoY
Diluted EPS
$-23.74
▼ 3868.3% YoY
Gross margin
2.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-08-05
Cencora, Inc. (COR) Q3 2020 Earnings Call Transcript
Revenue
$45.37B
▲ 0.3% YoY
Diluted EPS
$1.41
▼ 1.4% YoY
Gross margin
2.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-05-07
Cencora, Inc. (COR) Q2 2020 Earnings Call Transcript
Revenue
$47.42B
▲ 9.5% YoY
Diluted EPS
$4.64
▲ 3469.2% YoY
Gross margin
2.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-01-30
Cencora, Inc. (COR) Q1 2020 Earnings Call Transcript
Revenue
$47.86B
▲ 5.4% YoY
Diluted EPS
$0.90
▼ 51.1% YoY
Gross margin
2.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–30 of 30 earnings calls
Key facts CIK 1140859 CUSIP 03073E105 13F (30d) 42 filings 20 filers Visit website Investor relations